Efficacy, Safety and Tolerability of Cadazolid in Subjects With Clostridium Difficile Associated Diarrhea (CDAD)

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2011
Cadazolid is a new antibiotic developed for the treatment of Clostridiun difficile associated diarrhea (CDAD), also known as Clostridium Difficile Infection (CDI). The purpose of the study was to evaluate the efficacy and safety of different doses of cadazolid in order to find the dose of cadazolid to be used for further clinical development of the compound in subjects with CDAD.
Epistemonikos ID: 39d0e69591c52ee5cbc5c48f30c5a5c3b81f975f
First added on: May 06, 2024